Arteriosclerosis  >>  Zontivity (vorapaxar)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Zontivity (vorapaxar) / Merck (MSD)
NCT00132912 / 2005-001890-83: Safety of SCH 530348 in Subjects Undergoing Non-Emergent Percutaneous Coronary Intervention (Study P03573)

Completed
2
1030
NA
SCH 530348
Merck Sharp & Dohme LLC
Arterial Obstructive Diseases, Coronary Disease
01/07
01/07
MK-5348-016, NCT00684203: Trial to Assess the Safety and Effects of Vorapaxar in Japanese Subjects With Acute Coronary Syndrome (P04772; )

Completed
2
120
Japan
Vorapaxar, Placebo, Aspirin, ASA, acetylsalicylic acid, Clopidogrel
Merck Sharp & Dohme LLC
Atherosclerosis, Myocardial Ischemia, Myocardial Infarction
10/07
10/07

Download Options